Ardelyx Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
/ 
Frequently asked questions
To buy Ardelyx Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Ardelyx Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Ardelyx Inc. is ARDX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Ardelyx Inc. has its primary listing on NASDAQ. You can trade Ardelyx Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Ardelyx Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Ardelyx Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Ardelyx Inc..